Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double Blind, Randomized Trial of Alirocumab and Plaque Regression in Peripheral Arterial Disease

NCT02959047 is registered in ClinicalTrials.gov with University of Virginia as lead sponsor.

NCT NCT02959047
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02959047 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double Blind, Randomized Trial of Alirocumab and Plaque Regression in Peripheral Arterial Disease
Lead sponsor
University of Virginia
Phase
Phase 4
Overall status
Completed
Start date
July 17, 2017
Completion date
May 8, 2023
Enrollment
40 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral arterial disease